Assessments, Treatments and Modeling in Aging and Neurological Disease

Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books. Dr Rajkumar Rajendram is a clinician scientist with a focus on internal medicine, anaesthesia, intensive care and peri-operative medicine. He graduated with distinctions from Guy’s, King’s and St. Thomas Medical School, King’s College London in 2001. As an undergraduate he was awarded several prizes, merits and distinctions in pre-clinical and clinical subjects. Dr Rajendram began his post-graduate medical training in general medicine and intensive care in Oxford. He attained membership of the Royal College of Physicians (MRCP) in 2004 and completed specialist training in acute and general medicine in Oxford in 2010. Dr Rajendram subsequently practiced as a Consultant in Acute General Medicine at the John Radcliffe Hospital, Oxford. Dr Rajendram also trained in anaesthesia and intensive care in London and was awarded a fellowship of the Royal College of Anaesthetists (FRCA) in 2009. He completed advanced training in regional anaesthesia and intensive care. He was awarded a fellowship of the Faculty of Intensive Care Medicine (FFICM) in 2013 and obtained the European diploma of intensive care medicine (EDIC) in 2014. He then moved to the Royal Free London Hospitals as a Consultant in Intensive Care, Anaesthesia and Peri-operative Medicine. He has been a fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) and the Royal College of Physicians of London (FRCP Lond) since 2017 and 2019 respectively. He is currently a Consultant in Internal Medicine at King Abdulaziz Medical City, National Guard Heath Affairs, Riyadh, Saudi Arabia.Dr Rajendram’s focus on improving outcomes from Coronavirus Disease 2019 (COVID-19) has involved research on point of care ultrasound and phenotypes of COVID-19. Dr Rajendram also recognises that nutritional support is a fundamental aspect of medical care. This is particularly important for patients with COVID-19. As a clinician scientist he has therefore devoted significant time and effort into nutritional science research and education. He is an affiliated member of the Nutritional Sciences Research Division of King’s College London and has published over 400 textbook chapters, review articles, peer-reviewed papers and abstracts.

• I. Introductory chapters: Setting the scene for the neuroscience of aging1. The concept of productive aging2. Quality of life in the over 80s3. Successful aging and diet4. The impact of positive social relations on the quality of life of older people. An alternative to medicalization from an integral perspective5. The brain in life span: Use of phase fMagnetic Resonance Imaging (MRI)6. Neuronal structure in aging: cytoskeleton in health and disease7. Sporadic Alzheimer's Triad: Age, Sex, and ApoE8. How polymorphisms impact: BDNF polymorphism, inhibitory performance and the elderly9. Menopause as an aging process and alcohol misuse10. Brain banking and aging II. Impairments and Diseases11. Dementia or no dementia in the very elderly. Why?12. Neuropsychology, Social Cognition and Loss of Insight in Frontotemporal Dementia13. Neuroinflammation in the elderly14. Cortical microinfarcts and the aging brain15. Vascular brain injury and neurodegeneration in elderly racial and ethnic minority populations16. Hearing loss amongst the elderly17. Aging Auditory Cortex: The Impact of Reduced Inhibition on Function18. Aging and vestibular disorders19. Brain aging in HIV and antiretrovirals 20. Antioxidants, Methylmercury, and Aging21. Aging and the effects of ethanol on the brain: Comparing the effects of different agingIII. Biomarkers and Diagnosis 22. Aging brain: Radiological biomarkers23. Plasma ADAM10 as a biomarker of mental impairment in the elderly24. Circulating microRNAs as biomarkers of healthy elderly25. DHEA as a biomarker of aging in humans and nonhuman primates: Synthesis, neuroprotection and cognitive function26. Evaluation of subjective memory abilities in elderly people27. The Functional Activities Questionnaire: Applications to aging28. Autobiographical memory as a diagnostic tool in aging29. Assessment tools for subjective memory abilities in elderly people30. Knowledge of Memory AgingIV. Management and Treatments31. Pharmacological use of transient receptor potential (TRP) ion channel antagonists in neurological disease: Effects on swallowing and implications for nutrition32. Aripiprazole: Features and use in the aged33. Cognition-Enhancing Drugs and Applications to Aging34. Creatine supplementation and impact on the aging brain35. Photobiomodulation as a brain-boosting strategy in aging36. Innovation in deep brain stimulation in aging: a focus on Parkinson Disease37. Exergames: What they are and how they can be used to improve cognition in aging38. Linking cognitive decline and ballroom dance as a therapeutic intervention in the elderly39. Active experiencing training in the elderly40. Psychiatric self-management, smartphone apps and older adults41. Psychosocial Interventions for Suicide Prevention in the Elderly: Advances and Future DirectionsV. Models and Modelling42. D-galactose-induced aging and brain mitochondria43. Drosophila as a model organism in ageing research44. The Zebrafish (Danio rerio) and its uses for understanding the neuroscience of aging: applications and observation45. Murine models of primary Tauopathy as a model of aging46. Modelling nutrition and brain aging in rodents47. Modelling primates and neurological aging: A focus on Alzheimer's disease48. Linking aging and animal models to neurodegeneration: The Striatum, Substantia Nigra and Parkinson's Disease49. Behavioral evaluation of agingVI. Resources50. Research and recommended resources in the neuroscience of aging

"This book is unique in its approach to a myriad of topics in aging. I agree with the authors that most books tend to be highly specialized and do not cover the valuable number of topics addressed by this book. I commend them for achieving their objectives. They do so at the expense of not fully tackling any specific topic(s), but this makes the book very useful for a larger audience. I am not aware of a comparable book in this sense." --© Doody’s Review Service, 2021, Sasha Alick-Lindstrom, MD, reviewer, expert opinion